Published in J Eur Acad Dermatol Venereol on March 01, 2001
Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol (2003) 1.22
A Double-blind, Placebo-controlled Study Evaluating the Efficacy of an Oral Supplement in Women with Self-perceived Thinning Hair. J Clin Aesthet Dermatol (2012) 0.88
Chronic restraint stress inhibits hair growth via substance P mediated by reactive oxygen species in mice. PLoS One (2013) 0.87
Psychosocial impact of cicatricial alopecias. Indian J Dermatol (2011) 0.86
Androgenetic Alopecia: Quality-of-life and Associated Lifestyle Patterns. Int J Trichology (2010) 0.85
Quality of Life in Cancer Patients with Disfigurement due to Cancer and its Treatments. Indian J Palliat Care (2011) 0.81
Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation. Radiat Oncol (2014) 0.80
The relationship between alopecia areata and alexithymia, anxiety and depression: a case-control study. Indian J Dermatol (2014) 0.80
Assessing quality of life in older adult patients with skin disorders. Glob J Health Sci (2012) 0.78
A 3-month, randomized, double-blind, placebo-controlled study evaluating the ability of an extra-strength marine protein supplement to promote hair growth and decrease shedding in women with self-perceived thinning hair. Dermatol Res Pract (2015) 0.76
Health-related quality of life in patients with primary cutaneous amyloidosis. PLoS One (2015) 0.75
Quality of life in women with female pattern hair loss and the impact of topical minoxidil treatment on quality of life in these patients. Exp Ther Med (2013) 0.75
The Perceived Stigma in Patients with Alopecia and Mental Disorder: A Comparative Study. Int J Trichology (2016) 0.75
Quality of life in alopecia areata: a sample of tunisian patients. Dermatol Res Pract (2013) 0.75
A Randomized, Double-blind, Placebo-controlled, Multi-center, Extension Trial Evaluating the Efficacy of a New Oral Supplement in Women with Self-perceived Thinning Hair. J Clin Aesthet Dermatol (2015) 0.75
Pigmented Hair-Thickening Fibers: A Camouflage Technique for Alopecia in Patients with Epidermolysis Bullosa. Skin Appendage Disord (2015) 0.75
Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People's Republic of China. Patient Prefer Adherence (2017) 0.75
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol (2001) 10.85
British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol (2009) 4.12
The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol (1994) 3.45
British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol (2005) 3.10
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol (2008) 2.53
Update on the use of ciclosporin in immune-mediated dermatoses. Br J Dermatol (2006) 2.49
The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol (1999) 2.37
The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol (1995) 2.12
Trigeminal trophic syndrome. Arch Dermatol (1979) 2.08
Solving probabilistic and statistical problems: a matter of information structure and question form. Cognition (2001) 2.08
The finger-tip unit--a new practical measure. Clin Exp Dermatol (1991) 1.88
Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants. Lancet (1987) 1.86
Regulation of SOS mutagenesis by proteolysis. Proc Natl Acad Sci U S A (1996) 1.84
Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol (2007) 1.78
Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. Br J Dermatol (2006) 1.77
Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet (1991) 1.75
Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br J Dermatol (1998) 1.72
Does flow character of cardiopulmonary bypass make a difference? J Thorac Cardiovasc Surg (1992) 1.71
The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol (1998) 1.70
Rapid evolution of a unique family of primate ribonuclease genes. Nat Genet (1995) 1.62
Determinants of cervical cancer screening in a poor area: results of a population-based survey in Rivas, Nicaragua. Trop Med Int Health (2002) 1.60
Multiple linear lichen planus in the lines of Blaschko. Br J Dermatol (1996) 1.60
Assessment of disease progress in psoriasis. Arch Dermatol (1989) 1.59
Subcellular partitioning of MRP RNA assessed by ultrastructural and biochemical analysis. J Cell Biol (1994) 1.54
Purpura and dermal thinning associated with high dose inhaled corticosteroids. BMJ (1990) 1.54
Cyclosporine in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol (1996) 1.51
Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51
Gap junctional coupling and patterns of connexin expression among neonatal rat lumbar spinal motor neurons. J Neurosci (1999) 1.49
The family impact of skin diseases: the Greater Patient concept. Br J Dermatol (2007) 1.49
Essentiality of copper in humans. Am J Clin Nutr (1998) 1.44
Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol (1997) 1.40
The rule of hand: 4 hand areas = 2 FTU = 1 g. Arch Dermatol (1992) 1.40
European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol (2012) 1.40
Should we discuss smoking histories with our cancer patients? Clin Oncol (R Coll Radiol) (2000) 1.39
Thalidomide usage in Wales: the need to follow guidelines. Br J Dermatol (2001) 1.39
Duodenojejunitis: is it idiopathic or is it Henoch-Schönlein purpura without the purpura? J Pediatr Gastroenterol Nutr (2000) 1.36
Enhancing global capacity in the surveillance, prevention, and control of chronic diseases: seven themes to consider and build upon. J Epidemiol Community Health (2008) 1.31
Operational aspects of bednet impregnation for community-based malaria control in Nicaragua, Ecuador, Peru and Colombia. Trop Med Int Health (1997) 1.30
Psoriasis--an index of disability. Clin Exp Dermatol (1987) 1.28
Effective prevention of atrial fibrillation by continuous atrial overdrive pacing after coronary artery bypass surgery. J Am Coll Cardiol (2000) 1.25
A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases. Br J Dermatol (2012) 1.25
Does smoking influence acne? Clin Exp Dermatol (1993) 1.25
In vivo stability of the Umu mutagenesis proteins: a major role for RecA. J Bacteriol (1996) 1.25
Practical use of a disability index in the routine management of acne. Clin Exp Dermatol (1992) 1.24
Rapid diagnosis of human brucellosis by SYBR Green I-based real-time PCR assay and melting curve analysis in serum samples. Clin Microbiol Infect (2005) 1.23
The cytotoxic enterotoxin of Aeromonas hydrophila induces proinflammatory cytokine production and activates arachidonic acid metabolism in macrophages. Infect Immun (2000) 1.21
Skin and nail fungi-almost beaten. BMJ (1999) 1.21
Carney's syndrome: complex myxomas. Report of four cases and review of the literature. Cardiovasc Surg (2002) 1.20
BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Bone Marrow Transplant (1997) 1.19
The Infants' Dermatitis Quality of Life Index. Br J Dermatol (2001) 1.18
Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol (2007) 1.17
Amyand's hernia: 10 years' experience. Surgeon (2009) 1.16
Dendritic cell longevity and T cell persistence is controlled by CD154-CD40 interactions. Eur J Immunol (2001) 1.15
Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant (2003) 1.14
Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases. Br J Dermatol (2012) 1.13
Determinants of glucose toxicity and its reversibility in the pancreatic islet beta-cell line, HIT-T15. Am J Physiol Endocrinol Metab (2000) 1.13
TCRgammadelta+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRgammadelta+ T-cells. Leukemia (2006) 1.11
Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol (2000) 1.09
A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples. Mol Pathol (2003) 1.07
Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients. J Clin Microbiol (1995) 1.07
Patient acceptable symptom state and OMERACT-OARSI set of responder criteria in joint replacement. Identification of cut-off values. Osteoarthritis Cartilage (2011) 1.06
The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis. Br J Dermatol (2007) 1.06
Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation. Leukemia (2007) 1.06
Yellow jacket venom allergens, hyaluronidase and phospholipase: sequence similarity and antigenic cross-reactivity with their hornet and wasp homologs and possible implications for clinical allergy. J Allergy Clin Immunol (1996) 1.06
Cutting edge: sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease. J Immunol (1999) 1.04
Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care (1994) 1.04
Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial. Br J Dermatol (2005) 1.03
Impaired quality of life of adults with skin disease in primary care. Br J Dermatol (2000) 1.03
Disseminated Trichosporon beigelii (cutaneum). Cancer (1981) 1.02
Cutaneous IgA-associated vasculitis induced by alcohol. Br J Dermatol (2005) 1.02
Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial. Br J Dermatol (2006) 1.02
The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT). Biomed Imaging Interv J (2007) 1.02
Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol (2001) 1.02
An investigation of the pharmacokinetics of topical terbinafine (Lamisil) 1% cream. Br J Dermatol (1992) 1.02
Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors. Histol Histopathol (2006) 1.02
Non-clinical influences on clinical decision-making: a major challenge to evidence-based practice. J R Soc Med (2010) 1.01
The 'dry' non-eczematous skin associated with atopic eczema. Br J Dermatol (1980) 1.01
The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol (1997) 1.00
What do members of the National Eczema Society really want? Clin Exp Dermatol (1993) 1.00
Expression of the CD117 antigen (c-Kit) on normal and myelomatous plasma cells. Br J Haematol (1996) 0.99
The importance of educational and psychological factors in Parkinson's disease quality of life. Eur J Neurol (2002) 0.99
Staphylococcus aureus re-colonization in atopic dermatitis: beyond the skin. Clin Exp Dermatol (2005) 0.99
The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation. Leukemia (2012) 0.99
Three types of erythromelalgia. BMJ (1990) 0.98
Disseminated mycoses in a dog by Paecilomyces sp. J Vet Med A Physiol Pathol Clin Med (2000) 0.98
How much disability is caused by acne? Clin Exp Dermatol (1989) 0.98
Juvenile hyaline fibromatosis. Br J Dermatol (1983) 0.97
The role of CD40-CD154 interactions in the regulation of cell mediated immunity. Immunol Invest (2000) 0.97
Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification. Br J Haematol (1986) 0.97
Free tissue failure is not an all-or-none phenomenon. Plast Reconstr Surg (1995) 0.97
Edema of the uvula: etiology, risk factors, diagnosis, and treatment. J Investig Allergol Clin Immunol (2010) 0.96
Comparison of vaccine strains and the virus causing the 1986 foot-and-mouth disease outbreak in Spain: epizootiological analysis. Virus Res (1990) 0.95
Acne sans P. acnes. J Eur Acad Dermatol Venereol (2012) 0.95
Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients. Br J Dermatol (2006) 0.95
Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology (2015) 0.95
Effect of erythromycin on gastric motility in mechanically ventilated critically ill patients: a double-blind, randomized, placebo-controlled study. Crit Care Med (1995) 0.94